Levofloxacin Injection, Solution
Product Images NDC 36000-045

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Levofloxacin (NDC 36000-045). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Baxter Healthcare Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (8e9a2fd5 Afc9 473d A9fd 17db184392fb 01)

Chemical structure of levofloxacin shown with its molecular arrangement including a fluorine atom, carboxyl group, and a piperazine ring, consistent with its 25 mg/mL injectable formulation by Baxter Healthcare Corporation.*

FDA Label Image

Figure 2 (8e9a2fd5 Afc9 473d A9fd 17db184392fb 02)

A line graph comparing plasma concentration (µg/mL) over time (hours) for 750 mg Levofloxacin administered orally as a tablet versus intravenously via a 90-minute infusion. The plasma concentration peaks quickly with intravenous infusion and declines over time for both administration routes.*

FDA Label Image

Figure 3 (8e9a2fd5 Afc9 473d A9fd 17db184392fb 03)

A pharmacokinetic graph showing plasma concentration (µg/mL) of Levofloxacin over time (hours) comparing 500 mg oral tablet versus 500 mg intravenous administration. The plot includes two lines with markers indicating concentration decline from peak to near zero over 36 hours.*

FDA Label Image

C:\users\parmarm\desktop\8e9a2fd5-afc9-473d-a9fd-17db184392fb-04 (8e9a2fd5 Afc9 473d A9fd 17db184392fb 04)

Levofloxacin Injection 500 mg/20 mL (25 mg/mL) single-use vial label by Baxter Healthcare Corporation. The label states the product is a concentrated solution for intravenous infusion requiring further dilution. Storage instructions include 20°C to 25°C and protection from light. It also mentions the product is Rx only and provides manufacturer information for Baxter Pharmaceuticals India Private Ltd.*

FDA Label Image

C:\users\parmarm\desktop\8e9a2fd5-afc9-473d-a9fd-17db184392fb-05 (8e9a2fd5 Afc9 473d A9fd 17db184392fb 05)

Levofloxacin Injection in 5% Dextrose, 250 mg (5 mg/mL) in 50 mL single-use container by Baxter Healthcare Corporation. The label indicates intravenous infusion use, instructions to infuse over 60 minutes, and includes handling and storage precautions. Manufactured by Baxter Pharmaceuticals India Private Ltd.*

FDA Label Image

C:\users\parmarm\desktop\8e9a2fd5-afc9-473d-a9fd-17db184392fb-06 (8e9a2fd5 Afc9 473d A9fd 17db184392fb 06)

Levofloxacin Injection in 5% Dextrose 500 mg (5 mg/mL) in a 100 mL container label by Baxter Healthcare Corporation. The label includes dosing instructions, storage warnings, and manufacturer information from Baxter Pharmaceuticals India Private Ltd. It notes the product is for intravenous infusion and single use only, with no natural rubber latex in the container closure.*

FDA Label Image

C:\users\parmarm\desktop\8e9a2fd5-afc9-473d-a9fd-17db184392fb-07 (8e9a2fd5 Afc9 473d A9fd 17db184392fb 07)

Levofloxacin Injection in 5% Dextrose 5 mg/mL (750 mg in 150 mL) intravenous infusion solution manufactured by Baxter Healthcare Corporation. The label instructs use immediately once removed from the overwrap and notes the product is for single use, with no natural rubber latex in container closure. Manufactured by Baxter Pharmaceuticals India Private Ltd.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.